Ionis is a drug discovery company that develops and commercializes ribonucleic acid-targeted therapeutics for cardiovascular and neurological diseases
Read moreAnnual Revenue
$840.8M
Ionis Pharmaceuticals's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 1.8B. Over the last four quarters, Ionis Pharmaceuticals's revenue has grown by 12.9%. Specifically, in Q1 2022's revenue was $141.9M; in Q4 2021, it was $440M; in Q3 2021, it was $133.1M; in Q2 2021, Ionis Pharmaceuticals's revenue was $125.8M.